Virtual reality may ease chemo brain in cancer survivors

NCT ID NCT05907265

First seen Apr 26, 2026 · Last updated Jun 23, 2026 · Updated 10 times

Summary

This study tests whether immersive virtual reality (VR) exercises can improve memory, attention, and thinking speed in people with cancer who have mental fogginess after chemotherapy. Sixty participants will either use VR-based cognitive, physical, and mindfulness training or do similar activities on paper. The goal is to see if VR leads to better cognitive function, emotional well-being, and quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Consorci Sanitari de Terrassa

    RECRUITING

    Terrassa, 08227, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

immersive virtual reality (IVR) training combining cognitive exercises, physical activity, and mindfulness

What this could lead to

If it works, this could offer a non-drug way to help cancer survivors think more clearly and feel better emotionally after chemotherapy.

What could go wrong

This is a small, early-stage trial with only 60 participants, so results may not apply to everyone. The benefits of virtual reality over traditional methods are still unproven.

Conditions

The condition(s) this trial relates to.

cancer Cognitive Dysfunction neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.